This page lists all pharmaceutical reports related to the field of GenitoUrinary Tract Disorders. The reports include market research reports and pipeline analyses.
Displaying 51 - 76 of 76 results
- How to Conduct Clinical Trials in China
- Erectile Dysfunction Market Assessment & Analysis 2007-2022
- Pipeline and Commercial Insight: Urinary Incontinence - Lifecycle management strategies
- Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
- Biogenerics - The World Market: Biosimilars and Biologics at a Crossroads
- The Fastest Growing Biotechnology Companies: Growth strategies, comparative analyses and company profiles
- The Future of Targeted Therapeutics: Key technologies, new therapy area applications and leading players
- Outsourcing in Drug Discovery
- Monoclonal Antibodies Report: 2008 Update
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Ion Channel Trends 2008
- GPCR Screening & Profiling Trends 2008
- The Future of RNAi Therapeutics: Drug Pipelines and Prospects
- Two pharmaceutical reports for the price of one - End of year offer
- Womens Health: Worldwide Prescription Drug Markets
- Pharmaceutical Company Outlook to 2013
- Womens Health 2009: Worldwide Prescription Drug Markets
- Early Stage Drug Safety Strategies and Risk Management: Maximizing opportunities towards achieving clinical success
- New Approaches to Pharma Research and Development: Evolving strategies to rejuvenate Research and Development efficiency
- Accelerating Lead Generation: Emerging technologies and strategies
- Innovations in Protein Kinase Therapies: Company pipelines, therapeutic applications and market forecasts
- Monoclonal Antibody Therapeutics 2009-2024
- World Generics Market 2009-2024
- The World Market for Biosimilars and the Potential for US Follow-on Biologics
- Pipeline Insight: Endometriosis - New therapies near market while more innovative targets still needed
< Previous 1 | 2